A detailed history of Cortland Associates Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Cortland Associates Inc holds 5,563 shares of MRK stock, worth $562,808. This represents 0.08% of its overall portfolio holdings.

Number of Shares
5,563
Previous 5,539 0.43%
Holding current value
$562,808
Previous $685,000 7.88%
% of portfolio
0.08%
Previous 0.09%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$111.15 - $128.97 $2,667 - $3,095
24 Added 0.43%
5,563 $631,000
Q2 2024

Jul 29, 2024

BUY
$123.8 - $132.96 $2,847 - $3,058
23 Added 0.42%
5,539 $685,000
Q1 2024

Apr 22, 2024

SELL
$113.24 - $131.95 $14,607 - $17,021
-129 Reduced 2.29%
5,516 $727,000
Q4 2023

Jan 30, 2024

BUY
$100.18 - $109.02 $2,704 - $2,943
27 Added 0.48%
5,645 $615,000
Q3 2023

Oct 27, 2023

SELL
$102.95 - $114.33 $6,691 - $7,431
-65 Reduced 1.14%
5,618 $578,000
Q2 2023

Aug 03, 2023

SELL
$108.61 - $118.38 $112,085 - $122,168
-1,032 Reduced 15.37%
5,683 $655,000
Q1 2023

Apr 20, 2023

BUY
$102.94 - $114.86 $15,955 - $17,803
155 Added 2.36%
6,715 $714,000
Q4 2022

Jan 27, 2023

SELL
$87.44 - $112.11 $14,864 - $19,058
-170 Reduced 2.53%
6,560 $0
Q3 2022

Nov 01, 2022

BUY
$84.53 - $94.96 $8,537 - $9,590
101 Added 1.52%
6,730 $580,000
Q2 2022

Jul 22, 2022

BUY
$83.49 - $94.64 $56,355 - $63,882
675 Added 11.34%
6,629 $604,000
Q1 2022

May 03, 2022

SELL
$73.51 - $82.4 $5,513 - $6,180
-75 Reduced 1.24%
5,954 $489,000
Q4 2021

Feb 01, 2022

BUY
$72.28 - $90.54 $5,421 - $6,790
75 Added 1.26%
6,029 $462,000
Q3 2020

Oct 21, 2020

SELL
$73.18 - $82.95 $7,098 - $8,046
-97 Reduced 1.6%
5,954 $494,000
Q2 2020

Jul 23, 2020

SELL
$70.42 - $80.13 $3,873 - $4,407
-55 Reduced 0.9%
6,051 $468,000
Q1 2020

Apr 30, 2020

SELL
$63.36 - $87.82 $3,358 - $4,654
-53 Reduced 0.86%
6,106 $470,000
Q4 2019

Jan 31, 2020

BUY
$77.58 - $87.54 $15,903 - $17,945
205 Added 3.44%
6,159 $560,000
Q3 2019

Nov 07, 2019

SELL
$76.08 - $82.93 $2,130 - $2,322
-28 Reduced 0.47%
5,954 $501,000
Q1 2019

Apr 26, 2019

SELL
$69.58 - $79.36 $263,708 - $300,774
-3,790 Reduced 38.78%
5,982 $498,000
Q4 2018

Feb 01, 2019

SELL
$65.24 - $75.71 $4,240 - $4,921
-65 Reduced 0.66%
9,772 $747,000
Q3 2018

Oct 30, 2018

SELL
$57.69 - $67.84 $1,096 - $1,288
-19 Reduced 0.19%
9,837 $698,000
Q4 2017

Jan 24, 2018

BUY
$51.62 - $61.64 $36,030 - $43,024
698 Added 7.62%
9,856 $555,000
Q3 2017

Oct 25, 2017

BUY
$58.67 - $63.13 $537,299 - $578,144
9,158
9,158 $586,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $256B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Cortland Associates Inc Portfolio

Follow Cortland Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cortland Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cortland Associates Inc with notifications on news.